🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary goal of this investigation is to determine the ability of recom...
Status
Completed
Location
Children's Healthcare of Atlanta
Start Date
2011-03
Trial ID
NCT01352143
Treatments Being Tested
This is a single arm, phase 4, prospective, open-label, United States singl...
Status
Terminated
Location
Indiana Hemophila @Thrombosis Center
Start Date
2019-05-15
Trial ID
NCT03921294
Treatments Being Tested
The purpose of this research is to understand if the medication called FEIB...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10
Trial ID
NCT05020483
This study aims to assess a fixed-dose regimen of activated prothrombin com...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02565836
The purpose of this dose-ranging pilot study is to compare Recombinant Acti...
Status
Terminated
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT00770718
Treatments Being Tested
The purpose of this study is to: * 1\. To evaluate the tolerability and sa...
Status
Completed
Location
University Hospital Center Zagreb
Start Date
2019-02-12
Trial ID
NCT02764489
Treatments Being Tested
The goal of this study will be to determine whether PCC confers any benefit...
Status
Withdrawn
Location
University of Utah Medical Center
Start Date
2015-04
Trial ID
NCT02429453
Treatments Being Tested
This is a single arm, phase 4, prospective, open-label, United States singl...
Status
Recruiting
Location
Indiana Hemophila @Thrombosis Center
Start Date
2022-07-25
Trial ID
NCT04567511
Treatments Being Tested
The purpose of the aPCC-emicizumab safety study is to investigate the hemos...
Status
Recruiting
Location
Children's Healthcare of Atlanta
Start Date
2026-09
Trial ID
NCT04563520
Treatments Being Tested
This trial is conducted in North America. The aim of this trial is to compa...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
1998-04
Trial ID
NCT01561391